InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,477.90
(
0.16%
)
US TECH 100
19,166.00
(
-0.05%
)
Dow Jones
39,127.80
(
0.04%
)
Brent Oil
84.45
(
0.31%
)
Bitcoin
60,931.57
(
-1.42%
)
Post# of 403050
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Jhawker

Send PM Follow Ignore
Followers 16
Posts 2342
Boards Moderated 0
Alias Born 07/05/2013

Jhawker

Re: None

Friday, 10/30/2020 11:27:27 AM

Friday, October 30, 2020 11:27:27 AM

Post# of 403050
Another failure! Go B!
“ In the latest blow to the hoped-for class of therapeutics, Regeneron, the maker of the antibody therapy that President Trump credited (along with dexamethasone, a steroid) for his swift recovery has stopped enrollment in its trial for seriously ill patients after an independent authority wared of a safety issue.
”
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent IPIX News
More IPIX News
InvestorsHub NewsWire

FEATURED POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • Jun 26, 2024 10:09 AM

HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM

Bantec's Howco Short Term Department of Defense Contract Wins Will Exceed $1,100,000 for the current Quarter • BANT • Jun 25, 2024 10:00 AM

ECGI Holdings Targets $9.7 Billion Equestrian Apparel Market with Allon Brand Launch • ECGI • Jun 25, 2024 8:36 AM

Avant Technologies Addresses Progress on AI Supercomputer-Driven Data Centers • AVAI • Jun 25, 2024 8:00 AM

Green Leaf Innovations, Inc. Expands International Presence with New Partnership in Dubai • GRLF • Jun 24, 2024 8:30 AM

Start posting your company's news
Only $200 per official company press release!